Bruker (BRKRP) Debt Ratio (2010 - 2026)
Bruker posted quarterly Debt Ratio of 0.27 for Q1 2026, down 23.48% year-on-year from 0.36 in Q1 2025, and down 8.97% on a QoQ basis from 0.3 in Q4 2025.
Bruker (BRKRP) has 17 years of Debt Ratio data on file, last reported at 0.27 in Q1 2026.
- For the quarter ending Q1 2026, Debt Ratio fell 23.48% year-over-year to 0.27; the trailing twelve-month figure through Mar 2026 stood at 0.27 (down 23.48% YoY), and the FY2025 full-year result was 0.3, down 15.87% from the prior year.
- Debt Ratio for Q1 2026 stood at 0.27, down from 0.3 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.38 in Q2 2025 and bottomed at 0.27 in Q1 2026.
- The 5-year median for Debt Ratio is 0.33 (2022), against an average of 0.33.
- The widest annual swing landed in 2022, when Debt Ratio surged 30.77%; it then decreased 23.48% in 2026.
- A 5-year view of Debt Ratio shows it stood at 0.33 in 2022, then declined by 9.89% to 0.3 in 2023, then gained by 18.05% to 0.36 in 2024, then dropped by 15.87% to 0.3 in 2025, then dropped by 8.97% to 0.27 in 2026.
- The last three Debt Ratio figures came in at 0.27 (Q1 2026), 0.3 (Q4 2025), and 0.31 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.31 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.32 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.31 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.25 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.04 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.25 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.27 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.18 |
| 10 | Bruker | - | - | 379.80 Mn | 0.27 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.27 |
| Dec 31, 2025 | 0.30 |
| Sep 30, 2025 | 0.31 |
| Jun 30, 2025 | 0.38 |
| Mar 31, 2025 | 0.36 |
| Dec 31, 2024 | 0.36 |
| Sep 30, 2024 | 0.38 |
| Jun 30, 2024 | 0.37 |
| Mar 31, 2024 | 0.31 |
| Dec 31, 2023 | 0.30 |
| Sep 30, 2023 | 0.32 |
| Jun 30, 2023 | 0.32 |
| Mar 31, 2023 | 0.33 |
| Dec 31, 2022 | 0.33 |
| Sep 30, 2022 | 0.35 |
| Jun 30, 2022 | 0.35 |
| Mar 31, 2022 | 0.34 |
| Dec 31, 2021 | 0.34 |
| Sep 30, 2021 | 0.26 |
| Jun 30, 2021 | 0.27 |
| Mar 31, 2021 | 0.27 |
| Dec 31, 2020 | 0.28 |
| Sep 30, 2020 | 0.29 |
| Jun 30, 2020 | 0.35 |
| Mar 31, 2020 | 0.34 |
| Dec 31, 2019 | 0.29 |
| Sep 30, 2019 | 0.22 |
| Jun 30, 2019 | 0.21 |
| Mar 31, 2019 | 0.15 |
| Dec 31, 2018 | 0.16 |
| Sep 30, 2018 | 0.13 |
| Jun 30, 2018 | 0.12 |
| Mar 31, 2018 | 0.12 |
| Dec 31, 2017 | 0.22 |
| Sep 30, 2017 | 0.24 |
| Jun 30, 2017 | 0.23 |
| Mar 31, 2017 | 0.21 |
| Dec 31, 2016 | 0.22 |
| Sep 30, 2016 | 0.20 |
| Jun 30, 2016 | 0.20 |
| Mar 31, 2016 | 0.17 |
| Dec 31, 2015 | 0.15 |
| Sep 30, 2015 | 0.20 |
| Jun 30, 2015 | 0.20 |
| Mar 31, 2015 | 0.20 |
| Dec 31, 2014 | 0.19 |
| Sep 30, 2014 | 0.19 |
| Jun 30, 2014 | 0.18 |
| Mar 31, 2014 | 0.17 |
| Dec 31, 2013 | 0.18 |
| Sep 30, 2013 | 0.18 |
| Jun 30, 2013 | 0.19 |
| Mar 31, 2013 | 0.19 |
| Dec 31, 2012 | 0.18 |
| Sep 30, 2012 | 0.19 |
| Jun 30, 2012 | 0.18 |
| Mar 31, 2012 | 0.18 |
| Dec 31, 2011 | 0.18 |
| Sep 30, 2011 | 0.15 |
| Jun 30, 2011 | 0.14 |
| Mar 31, 2011 | 0.07 |
| Dec 31, 2010 | 0.18 |